3BOLAND E A,GERY M,OSETERLEA,et al.Continuous subcutaneous insulininfusion:a new way to lower risk of severe bypoglycemia improve metabolic conerol,and enhance coping in adoleacents with type ldiabetes[J].Diabetes Care,1999,22(11):1284-1289.
4ZINMAN B.Insilin pump therapy and rapid acting insulin:what have we learned[J].lnt J Clin,2001,123 (Suppl):47-50.
5BODE B W,STEED R D,DAVIDSON P C.Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in typel diabetes[J].Diabetes Care,1996,19:324.
3[2]Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+T cells in the pathogenesis of organ-specific autoimmune diseases[J].Immunol Today,1995,16(1):34～38.
4[3]Andre-Schmutz I, Hindelang C, Benoist C,et al.Cellular and molecular changes accompanying the progression from insulitis to diabetes[J]. Eur J Immunol,1999,29:245～248.
5[4]Hussain MJ,Peakman M,Gallati H,et al.Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM [J]. Diabetologia,1996,39(1):60～65.
6[5]Suarez-Pinzon W,Strynadka K,Rabinovitch A.Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes[J]. Endocrinol,1996,137:5290～5292.
7Kaufman DL,Clare-Saizier M,Tian J, et al. Spontaneous loss of T-cell tolerance to glutmic acid decarboxylase in murine insulin-dependent diabetes[J]. Nature, 1993,366(6450) :69-72.
8Huttunen NP, Kaar M, Puukka R, et al. Clinical significance of urinary C- Peptide excretion in children with insulin - dependent diabetes mellitus[J]. Acta Paediatr Scand, 1989,78(2) :271 --277.
6Zinman B.Insulin pump therapy and rapid acting insulin: what have we learned. International Journal of Clinical Practice . 2001
7Lenhard M J,Reeves G D.Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Archives of Internal Medicine . 2001
8AmericanDiabetesAssociation.Hyperglycemiccrisesinpatientswith diabetesmellitus. Diabetes Care . 2001
9Pickup J,Keen H.Continuous subcutaneous insulin infusion at 25 years.Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care . 2002
10Boland EA,Grey M,Oestrele A,et al.Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care . 1999
